Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer


Sendur M. A. N., AKSOY S., YORGUN H., Ozdemir N., Yilmaz F. M., Yazici O., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.31, no.3, pp.547-556, 2015 (SCI-Expanded) identifier identifier identifier

Abstract

Purpose: